Found 51 hits Enz. Inhib. hit(s) with all data for entry = 50010374 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093917
(CHEMBL87729 | N-Decyl-4-[2-(4-fluoro-benzylsulfany...)Show SMILES CCCCCCCCCCNC(=O)CCCn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C30H40FN5O2S/c1-2-3-4-5-6-7-8-9-16-34-28(37)11-10-17-36-21-26(18-25-19-32-23-33-20-25)29(38)35-30(36)39-22-24-12-14-27(31)15-13-24/h12-15,19-21,23H,2-11,16-18,22H2,1H3,(H,34,37) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 0.100 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093916
(CHEMBL85885 | N-Dodecyl-2-[2-(4-fluoro-benzylsulfa...)Show SMILES CCCCCCCCCCCCNC(=O)Cn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C30H40FN5O2S/c1-2-3-4-5-6-7-8-9-10-11-16-34-28(37)21-36-20-26(17-25-18-32-23-33-19-25)29(38)35-30(36)39-22-24-12-14-27(31)15-13-24/h12-15,18-20,23H,2-11,16-17,21-22H2,1H3,(H,34,37) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 0.300 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50403796
(CHEMBL2111560)Show SMILES CCCCCCCC\C=C/CCCCCCCCNC(=O)CCCn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C38H54FN5O2S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-24-42-36(45)19-18-25-44-29-34(26-33-27-40-31-41-28-33)37(46)43-38(44)47-30-32-20-22-35(39)23-21-32/h9-10,20-23,27-29,31H,2-8,11-19,24-26,30H2,1H3,(H,42,45)/b10-9- | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093951
(4-[2-(4-Fluoro-benzylsulfanyl)-4-oxo-5-pyrimidin-5...)Show SMILES CCCCCCCCNC(=O)CCCn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C28H36FN5O2S/c1-2-3-4-5-6-7-14-32-26(35)9-8-15-34-19-24(16-23-17-30-21-31-18-23)27(36)33-28(34)37-20-22-10-12-25(29)13-11-22/h10-13,17-19,21H,2-9,14-16,20H2,1H3,(H,32,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 0.400 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093913
(4-[2-(4-Fluoro-benzylsulfanyl)-4-oxo-5-pyrimidin-5...)Show SMILES CCCCCCCC\C=C\CCCCCCCCNC(=O)CCCn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C38H54FN5O2S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-24-42-36(45)19-18-25-44-29-34(26-33-27-40-31-41-28-33)37(46)43-38(44)47-30-32-20-22-35(39)23-21-32/h9-10,20-23,27-29,31H,2-8,11-19,24-26,30H2,1H3,(H,42,45)/b10-9+ | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 0.700 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093935
(CHEMBL87741 | N-Dodecyl-2-[2-(4-fluoro-benzylsulfa...)Show SMILES CCCCCCCCCCCCN(C)C(=O)Cn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C31H42FN5O2S/c1-3-4-5-6-7-8-9-10-11-12-17-36(2)29(38)22-37-21-27(18-26-19-33-24-34-20-26)30(39)35-31(37)40-23-25-13-15-28(32)16-14-25/h13-16,19-21,24H,3-12,17-18,22-23H2,1-2H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50403797
(CHEMBL2111561)Show SMILES CCCCCCCC\C=C/CCCCCCCCNC(=O)Cn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C36H50FN5O2S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-22-40-34(43)27-42-26-32(23-31-24-38-29-39-25-31)35(44)41-36(42)45-28-30-18-20-33(37)21-19-30/h9-10,18-21,24-26,29H,2-8,11-17,22-23,27-28H2,1H3,(H,40,43)/b10-9- | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 1 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093928
(2-[2-(4-Fluoro-benzylsulfanyl)-4-oxo-5-pyrimidin-5...)Show SMILES Fc1ccc(CCCCCCNC(=O)Cn2cc(Cc3cncnc3)c(=O)nc2SCc2ccc(F)cc2)cc1 Show InChI InChI=1S/C30H31F2N5O2S/c31-26-10-6-22(7-11-26)5-3-1-2-4-14-35-28(38)19-37-18-25(15-24-16-33-21-34-17-24)29(39)36-30(37)40-20-23-8-12-27(32)13-9-23/h6-13,16-18,21H,1-5,14-15,19-20H2,(H,35,38) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093946
(4-[2-(4-Fluoro-benzylsulfanyl)-4-oxo-5-pyrimidin-5...)Show SMILES CCCCCCCNC(=O)CCCn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C27H34FN5O2S/c1-2-3-4-5-6-13-31-25(34)8-7-14-33-18-23(15-22-16-29-20-30-17-22)26(35)32-27(33)36-19-21-9-11-24(28)12-10-21/h9-12,16-18,20H,2-8,13-15,19H2,1H3,(H,31,34) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093926
(2-[2-(4-Fluoro-benzylsulfanyl)-4-oxo-5-pyrimidin-5...)Show SMILES CCCCCCCC\C=C\CCCCCCCCNC(=O)Cn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C36H50FN5O2S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-22-40-34(43)27-42-26-32(23-31-24-38-29-39-25-31)35(44)41-36(42)45-28-30-18-20-33(37)21-19-30/h9-10,18-21,24-26,29H,2-8,11-17,22-23,27-28H2,1H3,(H,40,43)/b10-9+ | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 2 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093912
(4-[2-(4-Fluoro-benzylsulfanyl)-4-oxo-5-pyrimidin-5...)Show SMILES CCCCCCCN(C)C(=O)CCCn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C28H36FN5O2S/c1-3-4-5-6-7-14-33(2)26(35)9-8-15-34-19-24(16-23-17-30-21-31-18-23)27(36)32-28(34)37-20-22-10-12-25(29)13-11-22/h10-13,17-19,21H,3-9,14-16,20H2,1-2H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093920
(4-[2-(4-Fluoro-benzylsulfanyl)-4-oxo-5-pyrimidin-5...)Show SMILES CCCCCCCCCCCCCCCCCCNC(=O)CCCn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C38H56FN5O2S/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-24-42-36(45)19-18-25-44-29-34(26-33-27-40-31-41-28-33)37(46)43-38(44)47-30-32-20-22-35(39)23-21-32/h20-23,27-29,31H,2-19,24-26,30H2,1H3,(H,42,45) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 4 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093941
(2-[2-(4-Fluoro-benzylsulfanyl)-4-oxo-5-pyrimidin-5...)Show SMILES CCCCCCCCNC(=O)Cn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C26H32FN5O2S/c1-2-3-4-5-6-7-12-30-24(33)17-32-16-22(13-21-14-28-19-29-15-21)25(34)31-26(32)35-18-20-8-10-23(27)11-9-20/h8-11,14-16,19H,2-7,12-13,17-18H2,1H3,(H,30,33) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093948
(4-[2-(4-Fluoro-benzylsulfanyl)-4-oxo-5-pyrimidin-5...)Show SMILES CCCCCCNC(=O)CCCn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C26H32FN5O2S/c1-2-3-4-5-12-30-24(33)7-6-13-32-17-22(14-21-15-28-19-29-16-21)25(34)31-26(32)35-18-20-8-10-23(27)11-9-20/h8-11,15-17,19H,2-7,12-14,18H2,1H3,(H,30,33) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 7 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093924
(2-[8-(4-Chloro-phenyl)-8-oxo-octylsulfanyl]-5-pyri...)Show SMILES Clc1ccc(cc1)C(=O)CCCCCCCSc1nc(=O)c(Cc2cncnc2)cn1Cc1cccs1 Show InChI InChI=1S/C28H29ClN4O2S2/c29-24-11-9-22(10-12-24)26(34)8-4-2-1-3-5-13-37-28-32-27(35)23(15-21-16-30-20-31-17-21)18-33(28)19-25-7-6-14-36-25/h6-7,9-12,14,16-18,20H,1-5,8,13,15,19H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093953
(2-(4-Fluoro-benzylsulfanyl)-1-[2-(4-hexyl-phenyl)-...)Show SMILES CCCCCCc1ccc(CCn2cc(Cc3cncnc3)c(=O)nc2SCc2ccc(F)cc2)cc1 Show InChI InChI=1S/C30H33FN4OS/c1-2-3-4-5-6-23-7-9-24(10-8-23)15-16-35-20-27(17-26-18-32-22-33-19-26)29(36)34-30(35)37-21-25-11-13-28(31)14-12-25/h7-14,18-20,22H,2-6,15-17,21H2,1H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 12 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093950
(2-[2-(4-Fluoro-benzylsulfanyl)-4-oxo-5-pyrimidin-5...)Show SMILES CCCCCCCCN(C)C(=O)Cn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C27H34FN5O2S/c1-3-4-5-6-7-8-13-32(2)25(34)18-33-17-23(14-22-15-29-20-30-16-22)26(35)31-27(33)36-19-21-9-11-24(28)12-10-21/h9-12,15-17,20H,3-8,13-14,18-19H2,1-2H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 15 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093929
(2-[8-(4-Chloro-phenyl)-8-oxo-octylsulfanyl]-1-fura...)Show SMILES Clc1ccc(cc1)C(=O)CCCCCCCSc1nc(=O)c(Cc2cncnc2)cn1Cc1ccco1 Show InChI InChI=1S/C28H29ClN4O3S/c29-24-11-9-22(10-12-24)26(34)8-4-2-1-3-5-14-37-28-32-27(35)23(15-21-16-30-20-31-17-21)18-33(28)19-25-7-6-13-36-25/h6-7,9-13,16-18,20H,1-5,8,14-15,19H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 16 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093945
(2-[8-(4-Chloro-phenyl)-8-oxo-octylsulfanyl]-1-meth...)Show SMILES Cn1cc(Cc2cncnc2)c(=O)nc1SCCCCCCCC(=O)c1ccc(Cl)cc1 Show InChI InChI=1S/C24H27ClN4O2S/c1-29-16-20(13-18-14-26-17-27-15-18)23(31)28-24(29)32-12-6-4-2-3-5-7-22(30)19-8-10-21(25)11-9-19/h8-11,14-17H,2-7,12-13H2,1H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093957
(2-(4-Fluoro-benzylsulfanyl)-5-pyrimidin-5-ylmethyl...)Show SMILES CCCCCCCCCCCn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C27H35FN4OS/c1-2-3-4-5-6-7-8-9-10-15-32-19-24(16-23-17-29-21-30-18-23)26(33)31-27(32)34-20-22-11-13-25(28)14-12-22/h11-14,17-19,21H,2-10,15-16,20H2,1H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093933
(2-[2-(4-Fluoro-benzylsulfanyl)-4-oxo-5-pyrimidin-5...)Show SMILES CCCCCCCNC(=O)Cn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C25H30FN5O2S/c1-2-3-4-5-6-11-29-23(32)16-31-15-21(12-20-13-27-18-28-14-20)24(33)30-25(31)34-17-19-7-9-22(26)10-8-19/h7-10,13-15,18H,2-6,11-12,16-17H2,1H3,(H,29,32) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093922
(2-(4-Fluoro-benzylsulfanyl)-1-(9-phenyl-nonyl)-5-p...)Show SMILES Fc1ccc(CSc2nc(=O)c(Cc3cncnc3)cn2CCCCCCCCCc2ccccc2)cc1 Show InChI InChI=1S/C31H35FN4OS/c32-29-16-14-26(15-17-29)23-38-31-35-30(37)28(19-27-20-33-24-34-21-27)22-36(31)18-10-5-3-1-2-4-7-11-25-12-8-6-9-13-25/h6,8-9,12-17,20-22,24H,1-5,7,10-11,18-19,23H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 25 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093954
(2-[8-(4-Chloro-phenyl)-8-oxo-octylsulfanyl]-1-phen...)Show SMILES Clc1ccc(cc1)C(=O)CCCCCCCSc1nc(=O)c(Cc2cncnc2)cn1CCc1ccccc1 Show InChI InChI=1S/C31H33ClN4O2S/c32-28-14-12-26(13-15-28)29(37)11-7-2-1-3-8-18-39-31-35-30(38)27(19-25-20-33-23-34-21-25)22-36(31)17-16-24-9-5-4-6-10-24/h4-6,9-10,12-15,20-23H,1-3,7-8,11,16-19H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 34 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093939
(1-Benzyl-2-[8-(4-chloro-phenyl)-8-oxo-octylsulfany...)Show SMILES Clc1ccc(cc1)C(=O)CCCCCCCSc1nc(=O)c(Cc2cncnc2)cn1Cc1ccccc1 Show InChI InChI=1S/C30H31ClN4O2S/c31-27-14-12-25(13-15-27)28(36)11-7-2-1-3-8-16-38-30-34-29(37)26(17-24-18-32-22-33-19-24)21-35(30)20-23-9-5-4-6-10-23/h4-6,9-10,12-15,18-19,21-22H,1-3,7-8,11,16-17,20H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 36 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093918
(2-[8-(4-Chloro-phenyl)-8-oxo-octylsulfanyl]-1-ethy...)Show SMILES CCn1cc(Cc2cncnc2)c(=O)nc1SCCCCCCCC(=O)c1ccc(Cl)cc1 Show InChI InChI=1S/C25H29ClN4O2S/c1-2-30-17-21(14-19-15-27-18-28-16-19)24(32)29-25(30)33-13-7-5-3-4-6-8-23(31)20-9-11-22(26)12-10-20/h9-12,15-18H,2-8,13-14H2,1H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 39 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50085626
(2-[8-(4-Chloro-phenyl)-8-oxo-octylsulfanyl]-5-pyri...)Show SMILES Clc1ccc(cc1)C(=O)CCCCCCCSc1ncc(Cc2cncnc2)c(=O)[nH]1 Show InChI InChI=1S/C23H25ClN4O2S/c24-20-9-7-18(8-10-20)21(29)6-4-2-1-3-5-11-31-23-27-15-19(22(30)28-23)12-17-13-25-16-26-14-17/h7-10,13-16H,1-6,11-12H2,(H,27,28,30) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 54 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093952
(1-{2-[2-(4-Fluoro-benzylsulfanyl)-4-oxo-5-pyrimidi...)Show SMILES CCCCCCCNC(=O)NCCn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C26H33FN6O2S/c1-2-3-4-5-6-11-30-25(35)31-12-13-33-17-22(14-21-15-28-19-29-16-21)24(34)32-26(33)36-18-20-7-9-23(27)10-8-20/h7-10,15-17,19H,2-6,11-14,18H2,1H3,(H2,30,31,35) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093925
(2-[8-(4-Chloro-phenyl)-8-oxo-octylsulfanyl]-1-(3-p...)Show SMILES Clc1ccc(cc1)C(=O)CCCCCCCSc1nc(=O)c(Cc2cncnc2)cn1CCCc1ccccc1 Show InChI InChI=1S/C32H35ClN4O2S/c33-29-16-14-27(15-17-29)30(38)13-7-2-1-3-8-19-40-32-36-31(39)28(20-26-21-34-24-35-22-26)23-37(32)18-9-12-25-10-5-4-6-11-25/h4-6,10-11,14-17,21-24H,1-3,7-9,12-13,18-20H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 90 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093931
(2-(3,4-Difluoro-benzylsulfanyl)-1-phenethyl-5-pyri...)Show SMILES Fc1ccc(CSc2nc(=O)c(Cc3cncnc3)cn2CCc2ccccc2)cc1F Show InChI InChI=1S/C24H20F2N4OS/c25-21-7-6-18(11-22(21)26)15-32-24-29-23(31)20(10-19-12-27-16-28-13-19)14-30(24)9-8-17-4-2-1-3-5-17/h1-7,11-14,16H,8-10,15H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093949
(2-[8-(4-Chloro-phenyl)-8-oxo-octylsulfanyl]-1-(2-m...)Show SMILES COCCn1cc(Cc2cncnc2)c(=O)nc1SCCCCCCCC(=O)c1ccc(Cl)cc1 Show InChI InChI=1S/C26H31ClN4O3S/c1-34-13-12-31-18-22(15-20-16-28-19-29-17-20)25(33)30-26(31)35-14-6-4-2-3-5-7-24(32)21-8-10-23(27)11-9-21/h8-11,16-19H,2-7,12-15H2,1H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 110 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093942
(CHEMBL85932 | Octanoic acid {2-[2-(4-fluoro-benzyl...)Show SMILES CCCCCCCC(=O)NCCn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C26H32FN5O2S/c1-2-3-4-5-6-7-24(33)30-12-13-32-17-22(14-21-15-28-19-29-16-21)25(34)31-26(32)35-18-20-8-10-23(27)11-9-20/h8-11,15-17,19H,2-7,12-14,18H2,1H3,(H,30,33) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL KEGG PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093923
(2-Benzylsulfanyl-1-furan-2-ylmethyl-5-pyrimidin-5-...)Show InChI InChI=1S/C21H18N4O2S/c26-20-18(9-17-10-22-15-23-11-17)12-25(13-19-7-4-8-27-19)21(24-20)28-14-16-5-2-1-3-6-16/h1-8,10-12,15H,9,13-14H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 150 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093938
(2-(4-Fluoro-benzylsulfanyl)-1-phenethyl-5-pyrimidi...)Show SMILES Fc1ccc(CSc2nc(=O)c(Cc3cncnc3)cn2CCc2ccccc2)cc1 Show InChI InChI=1S/C24H21FN4OS/c25-22-8-6-19(7-9-22)16-31-24-28-23(30)21(12-20-13-26-17-27-14-20)15-29(24)11-10-18-4-2-1-3-5-18/h1-9,13-15,17H,10-12,16H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093914
(2-Benzylsulfanyl-5-pyrimidin-5-ylmethyl-1-thiophen...)Show InChI InChI=1S/C21H18N4OS2/c26-20-18(9-17-10-22-15-23-11-17)12-25(13-19-7-4-8-27-19)21(24-20)28-14-16-5-2-1-3-6-16/h1-8,10-12,15H,9,13-14H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| PubMed
| n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093956
(2-Benzylsulfanyl-1-phenethyl-5-pyrimidin-5-ylmethy...)Show SMILES O=c1nc(SCc2ccccc2)n(CCc2ccccc2)cc1Cc1cncnc1 Show InChI InChI=1S/C24H22N4OS/c29-23-22(13-21-14-25-18-26-15-21)16-28(12-11-19-7-3-1-4-8-19)24(27-23)30-17-20-9-5-2-6-10-20/h1-10,14-16,18H,11-13,17H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 210 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093930
(2-(3,4-Difluoro-benzylsulfanyl)-1-furan-2-ylmethyl...)Show SMILES Fc1ccc(CSc2nc(=O)c(Cc3cncnc3)cn2Cc2ccco2)cc1F Show InChI InChI=1S/C21H16F2N4O2S/c22-18-4-3-14(7-19(18)23)12-30-21-26-20(28)16(6-15-8-24-13-25-9-15)10-27(21)11-17-2-1-5-29-17/h1-5,7-10,13H,6,11-12H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 235 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093955
(2-(3-Fluoro-benzylsulfanyl)-1-furan-2-ylmethyl-5-p...)Show SMILES Fc1cccc(CSc2nc(=O)c(Cc3cncnc3)cn2Cc2ccco2)c1 Show InChI InChI=1S/C21H17FN4O2S/c22-18-4-1-3-15(8-18)13-29-21-25-20(27)17(7-16-9-23-14-24-10-16)11-26(21)12-19-5-2-6-28-19/h1-6,8-11,14H,7,12-13H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 250 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093947
(2-(4-Fluoro-benzylsulfanyl)-5-pyrimidin-5-ylmethyl...)Show SMILES Fc1ccc(CSc2nc(=O)c(Cc3cncnc3)cn2CCc2cccs2)cc1 Show InChI InChI=1S/C22H19FN4OS2/c23-19-5-3-16(4-6-19)14-30-22-26-21(28)18(10-17-11-24-15-25-12-17)13-27(22)8-7-20-2-1-9-29-20/h1-6,9,11-13,15H,7-8,10,14H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 250 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093936
(6-[2-(4-Fluoro-benzylsulfanyl)-4-oxo-5-pyrimidin-5...)Show SMILES CCCCNC(=O)CCCCCn1cc(Cc2cncnc2)c(=O)nc1SCc1ccc(F)cc1 Show InChI InChI=1S/C26H32FN5O2S/c1-2-3-12-30-24(33)7-5-4-6-13-32-17-22(14-21-15-28-19-29-16-21)25(34)31-26(32)35-18-20-8-10-23(27)11-9-20/h8-11,15-17,19H,2-7,12-14,18H2,1H3,(H,30,33) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 260 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093927
(2-(4-Fluoro-benzylsulfanyl)-1-methyl-5-pyrimidin-5...)Show InChI InChI=1S/C17H15FN4OS/c1-22-9-14(6-13-7-19-11-20-8-13)16(23)21-17(22)24-10-12-2-4-15(18)5-3-12/h2-5,7-9,11H,6,10H2,1H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 285 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093915
(2-(4-Fluoro-benzylsulfanyl)-1-furan-2-ylmethyl-5-p...)Show SMILES Fc1ccc(CSc2nc(=O)c(Cc3cncnc3)cn2Cc2ccco2)cc1 Show InChI InChI=1S/C21H17FN4O2S/c22-18-5-3-15(4-6-18)13-29-21-25-20(27)17(8-16-9-23-14-24-10-16)11-26(21)12-19-2-1-7-28-19/h1-7,9-11,14H,8,12-13H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093919
(2-Benzylsulfanyl-1-(3-phenyl-propyl)-5-pyrimidin-5...)Show SMILES O=c1nc(SCc2ccccc2)n(CCCc2ccccc2)cc1Cc1cncnc1 Show InChI InChI=1S/C25H24N4OS/c30-24-23(14-22-15-26-19-27-16-22)17-29(13-7-12-20-8-3-1-4-9-20)25(28-24)31-18-21-10-5-2-6-11-21/h1-6,8-11,15-17,19H,7,12-14,18H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093911
(2-Benzylsulfanyl-5-pyrimidin-5-ylmethyl-1-(2-thiop...)Show InChI InChI=1S/C22H20N4OS2/c27-21-19(11-18-12-23-16-24-13-18)14-26(9-8-20-7-4-10-28-20)22(25-21)29-15-17-5-2-1-3-6-17/h1-7,10,12-14,16H,8-9,11,15H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| PubMed
| n/a | n/a | 350 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093937
(2-(2-Fluoro-benzylsulfanyl)-1-furan-2-ylmethyl-5-p...)Show InChI InChI=1S/C21H17FN4O2S/c22-19-6-2-1-4-16(19)13-29-21-25-20(27)17(8-15-9-23-14-24-10-15)11-26(21)12-18-5-3-7-28-18/h1-7,9-11,14H,8,12-13H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 450 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093932
(1-Benzyl-2-benzylsulfanyl-5-pyrimidin-5-ylmethyl-1...)Show InChI InChI=1S/C23H20N4OS/c28-22-21(11-20-12-24-17-25-13-20)15-27(14-18-7-3-1-4-8-18)23(26-22)29-16-19-9-5-2-6-10-19/h1-10,12-13,15,17H,11,14,16H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 450 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093934
(2-Benzylsulfanyl-1-methyl-5-pyrimidin-5-ylmethyl-1...)Show InChI InChI=1S/C17H16N4OS/c1-21-10-15(7-14-8-18-12-19-9-14)16(22)20-17(21)23-11-13-5-3-2-4-6-13/h2-6,8-10,12H,7,11H2,1H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 660 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093940
(2-(3-Chloro-benzylsulfanyl)-1-furan-2-ylmethyl-5-p...)Show SMILES Clc1cccc(CSc2nc(=O)c(Cc3cncnc3)cn2Cc2ccco2)c1 Show InChI InChI=1S/C21H17ClN4O2S/c22-18-4-1-3-15(8-18)13-29-21-25-20(27)17(7-16-9-23-14-24-10-16)11-26(21)12-19-5-2-6-28-19/h1-6,8-11,14H,7,12-13H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 960 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50085649
(2-Benzylsulfanyl-5-pyrimidin-5-ylmethyl-1H-pyrimid...)Show InChI InChI=1S/C16H14N4OS/c21-15-14(6-13-7-17-11-18-8-13)9-19-16(20-15)22-10-12-4-2-1-3-5-12/h1-5,7-9,11H,6,10H2,(H,19,20,21) | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093943
(2-Benzylsulfanyl-1-(2-methoxy-ethyl)-5-pyrimidin-5...)Show InChI InChI=1S/C19H20N4O2S/c1-25-8-7-23-12-17(9-16-10-20-14-21-11-16)18(24)22-19(23)26-13-15-5-3-2-4-6-15/h2-6,10-12,14H,7-9,13H2,1H3 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
| PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |
Platelet-activating factor acetylhydrolase
(Homo sapiens (Human)) | BDBM50093944
(2-(4-Chloro-benzylsulfanyl)-1-furan-2-ylmethyl-5-p...)Show SMILES Clc1ccc(CSc2nc(=O)c(Cc3cncnc3)cn2Cc2ccco2)cc1 Show InChI InChI=1S/C21H17ClN4O2S/c22-18-5-3-15(4-6-18)13-29-21-25-20(27)17(8-16-9-23-14-24-10-16)11-26(21)12-19-2-1-7-28-19/h1-7,9-11,14H,8,12-13H2 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| PubMed
| n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
SmithKline Beecham Pharmaceuticals
Curated by ChEMBL
| Assay Description Inhibition of lipoprotein associated phospholipase A2 in human plasma |
Bioorg Med Chem Lett 10: 2557-61 (2001)
BindingDB Entry DOI: 10.7270/Q2B857C6 |
More data for this Ligand-Target Pair | |